Lexeo Therapeutics, Inc. — SCHEDULE 13G/A Filings
19 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Lexeo Therapeutics, Inc. (LXEO), sorted by most recent first. Each row links to the full filing on EdgarLookup. Lexeo Therapeutics, Inc. has filed 19 SCHEDULE 13G/A documents with the SEC since 2022. To view all SEC filings by Lexeo Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001619 | Mar 27, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016498 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016355 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-052896 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001231919-26-000153 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001315863-26-000099 | Jan 29, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-25-283019 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004978 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001193125-25-281249 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-108535 | Nov 7, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-002600 | Oct 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-021791 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-078747 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-075208 | Aug 7, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-002358 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-002233 | May 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001580642-25-001011 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-020474 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-000869 | Feb 12, 2025 | — |